| Literature DB >> 29802035 |
Hari R Singh1, Enzo Kopperger2, Friedrich C Simmel3.
Abstract
DNA-based nanorobots have been shown to sense and respond to molecular triggers, such as intracellular pH and cell surface receptors. A recent report describes DNA nanorobots as potential cancer therapeutic agents that can be programmed to trigger coagulation inside blood vessels at the tumor site, starving tumor cells to death.Entities:
Mesh：
Substances：
Year: 2018 PMID： 29802035 DOI： 10.1016/j.molmed.2018.05.001
Source DB: PubMed Journal: Trends Mol Med ISSN： 1471-4914 Impact factor: 11.951